The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequency of ALK rearrangement among patients (pts) with non small cell lung cancer (NSCLC), stratified by race.
 
Elshaddai Ephrem
No Relationships to Disclose
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; Bayer/Onyx; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Millennium
Research Funding - Advantagene (Inst); Ariad (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst)
 
Joshua Bauml
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Merck
Research Funding - Carevive Systems (Inst); Merck (Inst)
 
Carmen Guerra
Speakers' Bureau - Bristol-Myers Squibb (I); Gilead Sciences (I); Janssen (I); Pfizer (I)